Adam Vigil, Ph.D.
Affiliations: | 2008 | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Virology Biology, Genetics, ImmunologyGoogle:
"Adam Vigil"Parents
Sign in to add mentor| Adolfo Garcia-Sastre | grad student | 2008 | Mount Sinai School of Medicine | |
| (Recombinant Newcastle Disease Virus as a cancer therapeutic agent.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vigil A, Estélles A, Kauvar LM, et al. (2018) Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses. Antimicrobial Agents and Chemotherapy |
| Varga JJ, Vigil A, DeShazer D, et al. (2012) Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence. 3: 510-4 |
| Vigil A, Davies DH, Felgner PL. (2010) Defining the humoral immune response to infectious agents using high-density protein microarrays Future Microbiology. 5: 241-251 |
| Zamarin D, Martínez-Sobrido L, Kelly K, et al. (2009) Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 697-706 |
| Vigil A, Martinez O, Chua MA, et al. (2008) Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1883-90 |
| Vigil A, Park MS, Martinez O, et al. (2007) Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Research. 67: 8285-92 |